of CD4+ T cells and various inflammatory cytokines. 5, 6 These cytokines are produced by a variety of cells under chronic inflammatory conditions, which in turn leads to the development of immune-mediated inflammatory diseases. In OLP, several inflammatory cytokines, such as interleukin (IL)-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α, have been shown to have abnormal expression patterns. [7] [8] [9] However, the production and regulation of cytokines is complex. As such, studies that have focused on single or several inflammatory cytokines have produced contradictory results, and the mechanisms of cytokine regulation and their role in the chronic inflammatory environment of OLP are not understood.
In recent years, epigenetic mechanisms have been shown to play fundamental roles in a variety of biological processes including cell growth, development, differentiation, and genomic stability. Epigenetic changes can result in gene dysregulation, leading to various pathological conditions such as cancer or autoimmune diseases. 10, 11 Histone acetylation, a primary aspect of epigenetic mechanisms, plays key roles in remodeling chromatin conformation. The level of histone acetylation is highly dynamic and regulated by the opposing action of two enzyme families, histone deacetylases (HDACs) and histone acetyltransferases (HATs). HDACs remove acetyl groups from target histones, resulting in histone hypo-acetylation that restores the positive charge of histones leading to a closed chromatin configuration, which may potentially induce further epigenetic changes and altered gene expression. 12 There is increasing evidence that HDACs and their inhibitors may mediate the development of chronic inflammation by modulating the expression of many inflammatory cytokines and mediators such as IFN-γ, TNF-α, and interleukins. 13, 14 These studies have highlighted the involvement of histone modification in the pathogenesis of various autoimmune diseases including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). [15] [16] [17] To date, the involvement of epigenetic histone modification in the pathogenesis of OLP has not been examined. In this study, we investigated whether the histone modification pattern is altered in patients with OLP and examined the expression of eight members of four classes of HDACs in OLP CD4+ T cells. In addition, we also examined the relation of acetylation modification and peripheral blood cytokine levels in OLP. Manufacture Co., Ltd., Tianjin, China), and CD4+ T cells were isolated by negative selection using magnetic beads, according to the protocol of the manufacturer (R&D Systems, Inc., Minneapolis, MN).
| MATERIALS AND METHODS

| Patients
The purity of the CD4+ T cells was checked by flow cytometry and was typically >94%. 
|
| Measurement of HDAC activity
Isolation of nucleoprotein was performed using the EpiQuik Nuclear Extraction Kit (Epigentek). Nucleoprotein concentration was measured with the BCA ™ Protein Assay Kit (Pierce). HDAC activity was detected with the EpiQuik HDAC Activity Assay Kit (Epigentek).
2.5 | RNA isolation, cDNA synthesis, and real-time
RT-PCR
Total RNA was isolated from CD4+ T cells using the RNeasy Mini kit (Tiangen Biotech Co., Ltd., Beijing, China) according to the manufacturer's instructions. The RNA was stored at −80°C until use. First strand cDNA was synthesized using the Revert Aid ™ first strand cDNA synthesis kit (Takara, Shiga, Japan). Real-time semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) was performed with Sybr Green master mix using an ABI Prism 7300 System. A series of five dilutions of 1 RNA sample were included to generate a standard curve, and this was used to obtain relative concentrations of the transcript of interest in each of the RNA samples.
GAPDH was used as an endogenous control to normalize the amount of total RNA. Primers of eight members of HDACs genes were used (HDAC1, HDAC2, HDAC4, HDAC6, HDAC7, HDAC9, HDAC11, SIRT1), and that of GAPDH (Table 2 ).
| Cytokine array
For cytokine array analysis, peripheral blood samples were collected from EOLP patients (n = 6) and NEOLP patients (n = 5), and age and sex matched to healthy controls (n = 5). The human cytokine antibody array (RayBiotech, Norcross, GA) capable of measuring 40 cytokines was used according to the manufacturer's instructions.
Briefly, plasma was collected and stored at −80°C until use. While glass array slides were thawing to room temperature, the slides were blocked with 1× blocking buffer and incubated overnight at 4°C with 100 μL of plasma. Slides were washed and then incubated with 80 μL of biotin-conjugated anticytokines at room temperature for 1-2 hour. Slides were washed again and incubated at room temperature for 1 hour with Cy3 equivalent dye-conjugated streptavidin.
Each glass slide contained positive and negative internal controls.
Fluorescence was detected with a GenePix 4000 scanner (RayBiotech, Sunnyvale, CA) using the Cy3 channel, and signal intensity was obtained with the scanning software. The RayBio Analysis Tool software (RayBiotech) was used to evaluate signal intensities after 
| Statistical analysis
Experimental data were analyzed with the SPSS 24.0 software package and GraphPad Prism 7. Quantitative variables with a normal distribution were represented as in mean ± standard deviation ( x þ S). A t test was used to compare means between two groups. With three or more groups, ANOVA was used to compare means and the LSD-t test was used for multiple comparisons between means. Quantitative variables that were not normally distributed were represented as medians (P 25~P75 ). Wilcoxon rank sum test and Kruskal-Wallis H test were used to test the distribution of data, and the Spearman rank coefficient was used to determine the correlation between variables.
The statistical significance was set at P ≤ 0.05.
| RESULTS
| Aberrant global histone acetylation in OLP patients and controls
Compared with the control group, the histone H3 acetylation level in the OLP group was significantly lower (P = 0.0116). There was a significant difference in the histone H3 acetylation level among EOLP, NEOLP group and controls (P = 0.025). No significant difference was found in histone H3 acetylation level between EOLP and NEOLP groups (P > 0.05). No significant difference in the acetylation level of histone H4 was found between different groups (P > 0.05) (Figure 1 ).
| HDAC activity and related modifier HDAC genes
Compared with the control, the HDAC activity in the OLP group was significantly higher (P = 0.023). The HDAC activity in the EOLP The mRNA expression levels of related modifier HDAC genes were examined ( Table 2 ). The mRNA expression of HDAC6 and HDAC7 was significantly increased in OLP patients as compared to controls (both, P = 0.010). The mRNA expression of HDAC6 and HDAC7 in the EOLP group was higher that than in the NEOLP (P = 0.009 and P = 0.017, respectively) and the healthy control group (P < 0.001 and P = 0.001, respectively). Differences in the mRNA expression of other HDACs were not observed (all, P > 0.05) (Figure 2 ). The different results may be due to the different methods of detection, or the influence of differences in genetic background, lesion site, sex, and age between study populations.
We eventually identified five cytokines, IL-4, IL-16, MCP-1, TIMP-2, and MIP-1a that may be associated with histone modification. The level of HDAC6 mRNA expression positively correlated with MCP-1 production in the OLP group and the level of HDAC7 mRNA expression positively correlated with MIP-1a production in the EOLP group. HDAC6 and HDAC7 are both class II HDACs that have been found to be correlated with pathologic grade and tumor stage in several human cancers. 25, 26 They also appear to have crucial roles in T cell development and function. HDAC6 overexpression results in increased T cell migration and chemotaxis, 27 and nuclear export of HDAC7 regulates the expression of cytokines, cytokine receptors, and adhesion molecules. 28 A selective class II HDAC inhibitor has been found to decrease inflammatory cytokine levels in different cell lines. 29, 30 We can infer that the inhibition of HDAC activation, and the subsequent modification of chromatin status, change the molecular signature of mediators, leading to changes in the inflammatory environment.
In summary, our results revealed that histone modifications are apparently altered in peripheral blood of CD4+ T cells and are correlated with cytokine production in OLP patients. These findings provide novel insights into the pathogenesis of OLP. It is possible that the reversal of epigenetic changes could be an effective therapy for OLP. Further research is necessary to confirm our results, and to determine the causes leading to the deregulation of epigenetic mechanisms in patients with OLP.
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